Institutional investors purchased a net $183.4 thousand shares of NXTM during the quarter ended March 2018 and now own 85.07% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FLOSSBACH VON STORCH AG Bought 3.0 Million shares of NxStage Medical Inc
TIG ADVISORS LLC Bought 837.1 Thousand shares of NxStage Medical Inc
MARSHALL WACE LLP Bought 739.8 Thousand shares of NxStage Medical Inc